Discovery of Novel, Non-Peptide HIV-1 Protease Inhibitors by Pharmacophore Searching

Fifteen novel non-peptide HIV-1 protease inhibitors were identified by flexible 3D database pharmacophore searching of the NCI DIS 3D database. The pharmacophore query used in the search was derived directly from the X-ray determined structures of protease/inhibitor complexes. These 15 inhibitors, b...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of medicinal chemistry 1996-05, Vol.39 (10), p.2047-2054
Hauptverfasser: Wang, Shaomeng, Milne, G. W. A, Yan, Xinjian, Posey, Isadora J, Nicklaus, Marc C, Graham, Lisa, Rice, William G
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2054
container_issue 10
container_start_page 2047
container_title Journal of medicinal chemistry
container_volume 39
creator Wang, Shaomeng
Milne, G. W. A
Yan, Xinjian
Posey, Isadora J
Nicklaus, Marc C
Graham, Lisa
Rice, William G
description Fifteen novel non-peptide HIV-1 protease inhibitors were identified by flexible 3D database pharmacophore searching of the NCI DIS 3D database. The pharmacophore query used in the search was derived directly from the X-ray determined structures of protease/inhibitor complexes. These 15 inhibitors, belonging to nine different chemical classes, are promising leads for further development. The two best inhibitors found, NSC 32180, a “dimer” of 4-hydroxycoumarin, and NSC 117027, a “tetramer” of 2-hydroxy quinone, had ID50 values of 0.32 and 0.75 μM for HIV-1 protease inhibition, respectively, and two other inhibitors had ID50 values close to 1 μM. Among the potent inhibitors, NSC 158393 not only demonstrated activity against HIV-1 protease (ID50 1.7 μM) but also exhibited promising antiviral activity in HIV-1-infected CEM-SS cells (EC50 = 11.5 μM). Validation of the pharmacophore used in the search was accomplished by conformational analysis. The binding modes of the most potent inhibitor found in our studies, NSC 32180, were predicted employing docking and molecular dynamics techniques.
doi_str_mv 10.1021/jm950874+
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_78049778</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17028267</sourcerecordid><originalsourceid>FETCH-LOGICAL-a405t-1f6beba1adbfab90924a9afbf12ec73f453af9a3038fc655830f2bdc0ab3f11a3</originalsourceid><addsrcrecordid>eNqFkEFv0zAUxy3ENErZgQ-AlANCSCzs2U7i5IjKxqpVEKllh12sZ9emKUlc7HSi336eWroDh52epf9Pf7_3I-Qthc8UGL1Yd1UOpcg-vSAjmjNIsxKyl2QEwFjKCsZfkdchrAGAU8ZPyWlZZCwv-IgsvjZBu3vjd4mzyff4as_j6NPabIZmaZLr6W1Kk9q7wWAwybRfNaoZnA-J2iX1Cn2H2m1WzptkbtDrVdP_ekNOLLbBnB3mmPy8ulxMrtPZj2_TyZdZihnkQ0ptoYxCiktlUVVQsQwrtMpSZrTgNss52go58NLqIs9LDpappQZU3FKKfEw-7Hs33v3ZmjDILl5j2hZ747ZBimihEqJ8FqQCWMkKEcGPe1B7F4I3Vm5806HfSQryUbX8pzqi7w6dW9WZ5RE8qI35-0OOQWNrPfa6CUeMQxl_LCKW7rEmDObvMUb_W8Z9RC4X9VxOxM0c7uqZzJ5qUQe5dlvfR8P_b_cAUi2f4g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17028267</pqid></control><display><type>article</type><title>Discovery of Novel, Non-Peptide HIV-1 Protease Inhibitors by Pharmacophore Searching</title><source>MEDLINE</source><source>American Chemical Society Journals</source><creator>Wang, Shaomeng ; Milne, G. W. A ; Yan, Xinjian ; Posey, Isadora J ; Nicklaus, Marc C ; Graham, Lisa ; Rice, William G</creator><creatorcontrib>Wang, Shaomeng ; Milne, G. W. A ; Yan, Xinjian ; Posey, Isadora J ; Nicklaus, Marc C ; Graham, Lisa ; Rice, William G</creatorcontrib><description>Fifteen novel non-peptide HIV-1 protease inhibitors were identified by flexible 3D database pharmacophore searching of the NCI DIS 3D database. The pharmacophore query used in the search was derived directly from the X-ray determined structures of protease/inhibitor complexes. These 15 inhibitors, belonging to nine different chemical classes, are promising leads for further development. The two best inhibitors found, NSC 32180, a “dimer” of 4-hydroxycoumarin, and NSC 117027, a “tetramer” of 2-hydroxy quinone, had ID50 values of 0.32 and 0.75 μM for HIV-1 protease inhibition, respectively, and two other inhibitors had ID50 values close to 1 μM. Among the potent inhibitors, NSC 158393 not only demonstrated activity against HIV-1 protease (ID50 1.7 μM) but also exhibited promising antiviral activity in HIV-1-infected CEM-SS cells (EC50 = 11.5 μM). Validation of the pharmacophore used in the search was accomplished by conformational analysis. The binding modes of the most potent inhibitor found in our studies, NSC 32180, were predicted employing docking and molecular dynamics techniques.</description><identifier>ISSN: 0022-2623</identifier><identifier>EISSN: 1520-4804</identifier><identifier>DOI: 10.1021/jm950874+</identifier><identifier>PMID: 8642563</identifier><identifier>CODEN: JMCMAR</identifier><language>eng</language><publisher>Washington, DC: American Chemical Society</publisher><subject>AIDS/HIV ; Amino Acid Sequence ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Antiviral agents ; Binding Sites ; Biological and medical sciences ; Cell Line ; Crystallography, X-Ray ; HIV Protease Inhibitors - chemistry ; HIV Protease Inhibitors - metabolism ; HIV Protease Inhibitors - pharmacology ; HIV-1 - drug effects ; human immunodeficiency virus 1 ; Humans ; Information Systems ; Medical sciences ; Models, Molecular ; Molecular Sequence Data ; Pharmacology. Drug treatments</subject><ispartof>Journal of medicinal chemistry, 1996-05, Vol.39 (10), p.2047-2054</ispartof><rights>Copyright © 1996 American Chemical Society</rights><rights>1996 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a405t-1f6beba1adbfab90924a9afbf12ec73f453af9a3038fc655830f2bdc0ab3f11a3</citedby><cites>FETCH-LOGICAL-a405t-1f6beba1adbfab90924a9afbf12ec73f453af9a3038fc655830f2bdc0ab3f11a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/jm950874+$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/jm950874+$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>314,780,784,2765,27076,27924,27925,56738,56788</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=3088266$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8642563$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wang, Shaomeng</creatorcontrib><creatorcontrib>Milne, G. W. A</creatorcontrib><creatorcontrib>Yan, Xinjian</creatorcontrib><creatorcontrib>Posey, Isadora J</creatorcontrib><creatorcontrib>Nicklaus, Marc C</creatorcontrib><creatorcontrib>Graham, Lisa</creatorcontrib><creatorcontrib>Rice, William G</creatorcontrib><title>Discovery of Novel, Non-Peptide HIV-1 Protease Inhibitors by Pharmacophore Searching</title><title>Journal of medicinal chemistry</title><addtitle>J. Med. Chem</addtitle><description>Fifteen novel non-peptide HIV-1 protease inhibitors were identified by flexible 3D database pharmacophore searching of the NCI DIS 3D database. The pharmacophore query used in the search was derived directly from the X-ray determined structures of protease/inhibitor complexes. These 15 inhibitors, belonging to nine different chemical classes, are promising leads for further development. The two best inhibitors found, NSC 32180, a “dimer” of 4-hydroxycoumarin, and NSC 117027, a “tetramer” of 2-hydroxy quinone, had ID50 values of 0.32 and 0.75 μM for HIV-1 protease inhibition, respectively, and two other inhibitors had ID50 values close to 1 μM. Among the potent inhibitors, NSC 158393 not only demonstrated activity against HIV-1 protease (ID50 1.7 μM) but also exhibited promising antiviral activity in HIV-1-infected CEM-SS cells (EC50 = 11.5 μM). Validation of the pharmacophore used in the search was accomplished by conformational analysis. The binding modes of the most potent inhibitor found in our studies, NSC 32180, were predicted employing docking and molecular dynamics techniques.</description><subject>AIDS/HIV</subject><subject>Amino Acid Sequence</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Antiviral agents</subject><subject>Binding Sites</subject><subject>Biological and medical sciences</subject><subject>Cell Line</subject><subject>Crystallography, X-Ray</subject><subject>HIV Protease Inhibitors - chemistry</subject><subject>HIV Protease Inhibitors - metabolism</subject><subject>HIV Protease Inhibitors - pharmacology</subject><subject>HIV-1 - drug effects</subject><subject>human immunodeficiency virus 1</subject><subject>Humans</subject><subject>Information Systems</subject><subject>Medical sciences</subject><subject>Models, Molecular</subject><subject>Molecular Sequence Data</subject><subject>Pharmacology. Drug treatments</subject><issn>0022-2623</issn><issn>1520-4804</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkEFv0zAUxy3ENErZgQ-AlANCSCzs2U7i5IjKxqpVEKllh12sZ9emKUlc7HSi336eWroDh52epf9Pf7_3I-Qthc8UGL1Yd1UOpcg-vSAjmjNIsxKyl2QEwFjKCsZfkdchrAGAU8ZPyWlZZCwv-IgsvjZBu3vjd4mzyff4as_j6NPabIZmaZLr6W1Kk9q7wWAwybRfNaoZnA-J2iX1Cn2H2m1WzptkbtDrVdP_ekNOLLbBnB3mmPy8ulxMrtPZj2_TyZdZihnkQ0ptoYxCiktlUVVQsQwrtMpSZrTgNss52go58NLqIs9LDpappQZU3FKKfEw-7Hs33v3ZmjDILl5j2hZ747ZBimihEqJ8FqQCWMkKEcGPe1B7F4I3Vm5806HfSQryUbX8pzqi7w6dW9WZ5RE8qI35-0OOQWNrPfa6CUeMQxl_LCKW7rEmDObvMUb_W8Z9RC4X9VxOxM0c7uqZzJ5qUQe5dlvfR8P_b_cAUi2f4g</recordid><startdate>19960510</startdate><enddate>19960510</enddate><creator>Wang, Shaomeng</creator><creator>Milne, G. W. A</creator><creator>Yan, Xinjian</creator><creator>Posey, Isadora J</creator><creator>Nicklaus, Marc C</creator><creator>Graham, Lisa</creator><creator>Rice, William G</creator><general>American Chemical Society</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>7U9</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>19960510</creationdate><title>Discovery of Novel, Non-Peptide HIV-1 Protease Inhibitors by Pharmacophore Searching</title><author>Wang, Shaomeng ; Milne, G. W. A ; Yan, Xinjian ; Posey, Isadora J ; Nicklaus, Marc C ; Graham, Lisa ; Rice, William G</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a405t-1f6beba1adbfab90924a9afbf12ec73f453af9a3038fc655830f2bdc0ab3f11a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>AIDS/HIV</topic><topic>Amino Acid Sequence</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Antiviral agents</topic><topic>Binding Sites</topic><topic>Biological and medical sciences</topic><topic>Cell Line</topic><topic>Crystallography, X-Ray</topic><topic>HIV Protease Inhibitors - chemistry</topic><topic>HIV Protease Inhibitors - metabolism</topic><topic>HIV Protease Inhibitors - pharmacology</topic><topic>HIV-1 - drug effects</topic><topic>human immunodeficiency virus 1</topic><topic>Humans</topic><topic>Information Systems</topic><topic>Medical sciences</topic><topic>Models, Molecular</topic><topic>Molecular Sequence Data</topic><topic>Pharmacology. Drug treatments</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wang, Shaomeng</creatorcontrib><creatorcontrib>Milne, G. W. A</creatorcontrib><creatorcontrib>Yan, Xinjian</creatorcontrib><creatorcontrib>Posey, Isadora J</creatorcontrib><creatorcontrib>Nicklaus, Marc C</creatorcontrib><creatorcontrib>Graham, Lisa</creatorcontrib><creatorcontrib>Rice, William G</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wang, Shaomeng</au><au>Milne, G. W. A</au><au>Yan, Xinjian</au><au>Posey, Isadora J</au><au>Nicklaus, Marc C</au><au>Graham, Lisa</au><au>Rice, William G</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Discovery of Novel, Non-Peptide HIV-1 Protease Inhibitors by Pharmacophore Searching</atitle><jtitle>Journal of medicinal chemistry</jtitle><addtitle>J. Med. Chem</addtitle><date>1996-05-10</date><risdate>1996</risdate><volume>39</volume><issue>10</issue><spage>2047</spage><epage>2054</epage><pages>2047-2054</pages><issn>0022-2623</issn><eissn>1520-4804</eissn><coden>JMCMAR</coden><abstract>Fifteen novel non-peptide HIV-1 protease inhibitors were identified by flexible 3D database pharmacophore searching of the NCI DIS 3D database. The pharmacophore query used in the search was derived directly from the X-ray determined structures of protease/inhibitor complexes. These 15 inhibitors, belonging to nine different chemical classes, are promising leads for further development. The two best inhibitors found, NSC 32180, a “dimer” of 4-hydroxycoumarin, and NSC 117027, a “tetramer” of 2-hydroxy quinone, had ID50 values of 0.32 and 0.75 μM for HIV-1 protease inhibition, respectively, and two other inhibitors had ID50 values close to 1 μM. Among the potent inhibitors, NSC 158393 not only demonstrated activity against HIV-1 protease (ID50 1.7 μM) but also exhibited promising antiviral activity in HIV-1-infected CEM-SS cells (EC50 = 11.5 μM). Validation of the pharmacophore used in the search was accomplished by conformational analysis. The binding modes of the most potent inhibitor found in our studies, NSC 32180, were predicted employing docking and molecular dynamics techniques.</abstract><cop>Washington, DC</cop><pub>American Chemical Society</pub><pmid>8642563</pmid><doi>10.1021/jm950874+</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-2623
ispartof Journal of medicinal chemistry, 1996-05, Vol.39 (10), p.2047-2054
issn 0022-2623
1520-4804
language eng
recordid cdi_proquest_miscellaneous_78049778
source MEDLINE; American Chemical Society Journals
subjects AIDS/HIV
Amino Acid Sequence
Antibiotics. Antiinfectious agents. Antiparasitic agents
Antiviral agents
Binding Sites
Biological and medical sciences
Cell Line
Crystallography, X-Ray
HIV Protease Inhibitors - chemistry
HIV Protease Inhibitors - metabolism
HIV Protease Inhibitors - pharmacology
HIV-1 - drug effects
human immunodeficiency virus 1
Humans
Information Systems
Medical sciences
Models, Molecular
Molecular Sequence Data
Pharmacology. Drug treatments
title Discovery of Novel, Non-Peptide HIV-1 Protease Inhibitors by Pharmacophore Searching
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T07%3A33%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Discovery%20of%20Novel,%20Non-Peptide%20HIV-1%20Protease%20Inhibitors%20by%20Pharmacophore%20Searching&rft.jtitle=Journal%20of%20medicinal%20chemistry&rft.au=Wang,%20Shaomeng&rft.date=1996-05-10&rft.volume=39&rft.issue=10&rft.spage=2047&rft.epage=2054&rft.pages=2047-2054&rft.issn=0022-2623&rft.eissn=1520-4804&rft.coden=JMCMAR&rft_id=info:doi/10.1021/jm950874+&rft_dat=%3Cproquest_cross%3E17028267%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17028267&rft_id=info:pmid/8642563&rfr_iscdi=true